首页> 外国专利> Sustained sustained release liposome gel composition having active ingredient of hypoglycemic action and method for producing the same

Sustained sustained release liposome gel composition having active ingredient of hypoglycemic action and method for producing the same

机译:具有降血糖作用活性成分的缓释脂质体凝胶组合物及其制备方法

摘要

The present invention provides a slow and controlled released liposomal gel composition for subcutaneous administration comprises insulin or exenatide as active ingredient for reduction of blood sugar level and method of preparation thereof. Said controlled released composition has high bioavailability and is demonstrated to be able to sustain release therapeutically effective concentration of drug over a period of time and without rapid release of drug after initial administration. Method of preparing the controlled released composition of the present invention comprises the following steps: mixing insulin or exenatide, lipid and aqueous dispersion medium together; then mixing with poloxamer (e.g. F127 or P123) and/or gelatin and hyaluronic acid (HA) or the like gel solution so as to form a protective layer on surface of every lipid micro vesicles or nano-vesicles for use in intramuscular, abdominal and subcutaneous administration. A single administration of the present composition lasts 2 to 7 days to reduce side-effects, such as pain and irritation.
机译:本发明提供了一种用于皮下给药的缓慢且受控释放的脂质体凝胶组合物,其包含胰岛素或艾塞那肽作为降低血糖水平的活性成分及其制备方法。所述控释组合物具有高生物利用度,并且被证明能够在一段时间内维持治疗有效浓度的药物的释放,并且在初次给药后无需快速释放药物。制备本发明控释组合物的方法包括以下步骤:将胰岛素或艾塞那肽,脂质和水分散介质混合在一起;和然后与泊洛沙姆(例如F127或P123)和/或明胶和透明质酸(HA)或类似的凝胶溶液混合,以便在每个脂质微囊泡或纳米囊泡的表面上形成保护层,用于肌内,腹腔和腹部。皮下给药。本发明组合物的单次给药持续2至7天,以减少副作用,例如疼痛和刺激。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号